Shareholders to Vote on Reverse Stock Split and Dilutive Convertible Note Conversion to Maintain Nasdaq Listing and Secure Financing
MVIS is trading near its 52-week low of $0.51 (13% above the low).
Summary
MicroVision is asking shareholders to approve a reverse stock split to avoid delisting and to authorize the conversion of $43 million in convertible notes into shares, which is critical for its financing strategy.
Key Events · Corporate Governance and Compliance · MVIS
-
Reverse Stock Split Proposal
Shareholders will vote on authorizing a reverse stock split at a ratio between 1-for-5 and 1-for-15. This is a critical step to regain compliance with Nasdaq's $1.00 minimum bid price requirement by the July 13, 2026 deadline, following a notice of non-compliance received on January 12, 2026. This formalizes the plan announced in a concurrent 8-K filing.
-
Convertible Note Conversion Approval
The company is seeking approval for the issuance of shares upon conversion of $43 million in senior secured convertible notes, issued on February 23, 2026, at an initial conversion price of $0.8819 per share. This approval is required by Nasdaq rules due to the potential issuance of over 61 million shares (approximately 20% of outstanding shares prior to the notes' issuance). Without approval, the company would be forced to make substantial cash payments instead of issuing shares.
-
Significant Potential Dilution
The conversion of the $43 million in convertible notes could result in the issuance of approximately 61.3 million shares, representing about 20% dilution based on shares outstanding prior to the notes' issuance. While the conversion price is at a premium to the current stock price, the overall dilution is substantial.
-
Annual Meeting Agenda
The PRE 14A outlines the agenda for the Annual Meeting on July 10, 2026, which also includes the election of seven director nominees, a non-binding advisory vote on executive compensation, and the ratification of Baker Tilly US, LLP as the independent auditor.
Analysis · MVIS · Manufacturing
MicroVision is seeking shareholder approval for two critical proposals: a reverse stock split to regain Nasdaq compliance and the conversion of $43 million in senior secured convertible notes into shares. Failure to approve the note conversion would require substantial cash payments, while failure to approve the reverse split could lead to delisting. These actions are vital for the company's financial stability and market presence, reflecting ongoing challenges with its stock price and capital structure.
How filings like this one have moved
In the 30 days to Sep 19, 2026, 39.3% of the 354 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.46%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MVIS was trading at $0.57 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $200.4M. The 52-week trading range was $0.51 to $1.73. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.